Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Molecular and Cellular Endocrinology
|
February 14, 2013
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1
Yumei Xiong, Gayathri Swaminath, Qiong Cao, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Optimization of GPR40 Agonists for Type 2 Diabetes
Jiwen Jim Liu, Yingcai Wang, Zhihua Ma, et al.
Iscience
|
November 24, 2019
Signatures of the Evolution of Parthenogenesis and Cryptobiosis in the Genomes of Panagrolaimid Nematodes
Philipp H Schiffer, Etienne G J Danchin, Ann M Burnell, et al.
Microbiology Resource Announcements
|
February 13, 2019
Complete Genome Sequences of Mycobacterium smegmatis Phages Chewbacca, Reptar3000, and Riparian, Isolated in Las Vegas, Nevada
Alicia Salisbury, Erin Cassin, Kevin Ayala-Pineda, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors
Youngsook Shin, Julia Suchomel, Mario Cardozo, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists
Xiaohui Du, Paul J Dransfield, Daniel C-H Lin, et al.
NPJ Digital Medicine
|
January 30, 2021
Deep COVID DeteCT: an international experience on COVID-19 lung detection and prognosis using chest CT
Edward H Lee, Jimmy Zheng, Errol Colak, et al.
Microbiology Resource Announcements
|
December 12, 2018
Complete Genome Sequences of Paenibacillus larvae Phages Halcyone, Heath, Scottie, and Unity from Las Vegas, Nevada
Diane G Yost, Carolyn Chang, Lucy LeBlanc, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles
Yingcai Wang, Jiwen Jim Liu, Paul J Dransfield, et al.
Journal of Medicinal Chemistry
|
June 14, 2011
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia
Renata M Oballa, Liette Belair, W Cameron Black, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Molecular and Cellular Endocrinology
|
February 14, 2013
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1
Yumei Xiong, Gayathri Swaminath, Qiong Cao, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Optimization of GPR40 Agonists for Type 2 Diabetes
Jiwen Jim Liu, Yingcai Wang, Zhihua Ma, et al.
Iscience
|
November 24, 2019
Signatures of the Evolution of Parthenogenesis and Cryptobiosis in the Genomes of Panagrolaimid Nematodes
Philipp H Schiffer, Etienne G J Danchin, Ann M Burnell, et al.
Microbiology Resource Announcements
|
February 13, 2019
Complete Genome Sequences of Mycobacterium smegmatis Phages Chewbacca, Reptar3000, and Riparian, Isolated in Las Vegas, Nevada
Alicia Salisbury, Erin Cassin, Kevin Ayala-Pineda, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors
Youngsook Shin, Julia Suchomel, Mario Cardozo, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists
Xiaohui Du, Paul J Dransfield, Daniel C-H Lin, et al.
NPJ Digital Medicine
|
January 30, 2021
Deep COVID DeteCT: an international experience on COVID-19 lung detection and prognosis using chest CT
Edward H Lee, Jimmy Zheng, Errol Colak, et al.
Microbiology Resource Announcements
|
December 12, 2018
Complete Genome Sequences of Paenibacillus larvae Phages Halcyone, Heath, Scottie, and Unity from Las Vegas, Nevada
Diane G Yost, Carolyn Chang, Lucy LeBlanc, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles
Yingcai Wang, Jiwen Jim Liu, Paul J Dransfield, et al.
Journal of Medicinal Chemistry
|
June 14, 2011
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia
Renata M Oballa, Liette Belair, W Cameron Black, et al.
Page
of 7